HBHennie Boeije

Hennie Boeije

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hennie Boeije has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • (S)pionieren

    by Renate Verkaik, Emiel Bottenheft, Maaike Mul, Wendy van Zon, Sandra van Gerwen, Desirée Wevers, Jill Knapen, Hennie Boeije

  • Patients' and health professionals' views on shared decision‐making in age‐related macular degeneration care: A qualitative study

    by Mariska Scheffer, Juliane Menting, Ruud Roodbeen, Sandra van Dulmen, Manon van Hecke, Reinier Schlingemann, Ruth van Nispen, Hennie Boeije

    Background: Age‐related macular degeneration (AMD) is one of the principal causes of irreversible visual impairment in the older adult population. Recent evidence indicates that there are signs of undertreatment and overtreatment, underdiagnosis and insufficient information provision in AMD care. Shared decision‐making (SDM) can aid information sharing between patients and health professionals and enhances high‐quality care. This research aimed to gain insight into patients' and professionals' views on SDM in AMD care. Methods: Semi‐structured interviews were conducted with 20 patients with AMD and 19 health professionals in June and July 2020. Participants were recruited through hospitals, professional and patient associations and (social) networks. Sample representativeness was ensured in terms of sociodemographic and disease characteristics for patients, and profession‐related characteristics for health professionals. Interviews were analysed according to a predetermined coding framework. Results: Although SDM is receiving attention in AMD care, health professionals and patients experienced barriers in making shared decisions. The most common barriers reported included limitations in treatment options, time constraints, strict treatment guidelines and patients' comorbidity. Furthermore, most patients indicated that they were not (fully) informed about all aspects of AMD trajectory, such as the possibility to discontinue therapy or the long‐term and invasive character of treatment. Some patients expressed the need for a more empathic and person‐centred communication style from their health professional. Conclusion: The concerns raised by patients and health professionals suggest that there is room for improvement in delivery of SDM in AMD care. Findings from this study indicate that information provision and communication can be improved.


  • Top Cited Papers
    Open Access

    Factors influencing acceptance of technology for aging in place: A systematic review

    by Sebastiaan T.M. Peek, Eveline J.M. Wouters, Joost van Hoof, Katrien G. Luijkx, Hennie R. Boeije, Hubertus J.M. Vrijhoef